BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19966300)

  • 21. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.
    García-Gutiérrez L; Bretones G; Molina E; Arechaga I; Symonds C; Acosta JC; Blanco R; Fernández A; Alonso L; Sicinski P; Barbacid M; Santamaría D; León J
    Sci Rep; 2019 Dec; 9(1):18693. PubMed ID: 31822694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDK2 is required by MYC to induce apoptosis.
    Deb-Basu D; Aleem E; Kaldis P; Felsher DW
    Cell Cycle; 2006 Jun; 5(12):1342-7. PubMed ID: 16760655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p27Kip1 mediates addiction of ovarian cancer cells to MYCC (c-MYC) and their dependence on MYC paralogs.
    Prathapam T; Aleshin A; Guan Y; Gray JW; Martin GS
    J Biol Chem; 2010 Oct; 285(42):32529-38. PubMed ID: 20647308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myc and the cell cycle.
    Amati B; Alevizopoulos K; Vlach J
    Front Biosci; 1998 Feb; 3():d250-68. PubMed ID: 9468463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
    Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
    J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
    Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.
    Smartt HJ; Guilmeau S; Nasser SV; Nicholas C; Bancroft L; Simpson SA; Yeh N; Yang W; Mariadason JM; Koff A; Augenlicht LH
    Gastroenterology; 2007 Jul; 133(1):232-43. PubMed ID: 17631145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.
    Carbone CJ; Graña X; Reddy EP; Haines DS
    Cancer Res; 2007 May; 67(9):4130-7. PubMed ID: 17483323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
    Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines.
    Cooley A; Zelivianski S; Jeruss JS
    Cell Cycle; 2010 Dec; 9(24):4900-7. PubMed ID: 21150326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
    Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
    Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27.
    Cheng CW; Leong KW; Ng YM; Kwong YL; Tse E
    J Biol Chem; 2017 Dec; 292(52):21431-21441. PubMed ID: 29118189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSN5 specifically interacts with CDK2 and controls senescence in a cytoplasmic cyclin E-mediated manner.
    Yoshida A; Yoneda-Kato N; Kato JY
    Sci Rep; 2013; 3():1054. PubMed ID: 23316279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibition of Ras farnesylation leads to an increase in p27Kip1 and G1 cell cycle arrest.
    Reuveni H; Klein S; Levitzki A
    Eur J Biochem; 2003 Jul; 270(13):2759-72. PubMed ID: 12823546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity.
    Berns K; Hijmans EM; Bernards R
    Oncogene; 1997 Sep; 15(11):1347-56. PubMed ID: 9315103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E.
    Cheng PH; Rao XM; McMasters KM; Zhou HS
    PLoS One; 2013; 8(2):e57340. PubMed ID: 23437375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fargesin Inhibits EGF-Induced Cell Transformation and Colon Cancer Cell Growth by Suppression of CDK2/Cyclin E Signaling Pathway.
    Lee GE; Lee CJ; An HJ; Kang HC; Lee HS; Lee JY; Oh SR; Cho SJ; Kim DJ; Cho YY
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.
    Grimmler M; Wang Y; Mund T; Cilensek Z; Keidel EM; Waddell MB; Jäkel H; Kullmann M; Kriwacki RW; Hengst L
    Cell; 2007 Jan; 128(2):269-80. PubMed ID: 17254966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.